Search

New approaches in neurodevelopmental research increasingly seek to integrate enormous amounts of data through sophisticated informatics so as to determine the relationship between genotype and phenotypes, both structural and functional, as they change over time during development. Project...

Members of the CONP and dignitaries who attended the inaugural meeting on February 19, 2018. The project The Canadian Open Neuroscience Platform (CONP) is a national platform for the open sharing of neuroscience research data. It brings together many of the country’s leading scientists in basic and...

Recovery of movement after a spinal cord injury starts in the brain. Project Overview Recovery of movement after a spinal cord injury starts in the brain. Two-thirds of spinal cord injuries are not complete, meaning some connections and voluntary movement remain. In such cases, the nervous system...

“This new technology will help us establish and detect biomarkers. Because of this grant funding, we can test our new ideas – ideas we have developed together based on both of our individual experiences.” – Dr. Gerhard Multhaup Dr. Angela Genge has been working on clinical trials for ALS for years,...

Led by Dr. Elie Haddad from CHU Sainte-Justine in collaboration with Immugenia, this project includes an inter-provincial research collaboration Project Overview Led by Dr. Elie Haddad from CHU Sainte-Justine in collaboration with Immugenia, this project includes an inter-provincial research...

Motor neurons are extremely complex cells. Not only do they have an intricate set of inner workings, but they have a long wire-like portion called an axon that connects the central nervous system to muscles called an axon. Project Overview Motor neurons are extremely complex cells. Not only do they...

Epilepsy is a common neurological condition that affects 1-2% of the population. Project Overview Epilepsy is a common neurological condition that affects 1-2% of the population. Despite dozens of anticonvulsant medications, over a third of patients remain refractory to drugs and our goal is to...

Parkinson’s Disease (PD) and Amyotrophic Lateral Sclerosis (ALS) are two of the most common and devastating neurodegenerative diseases, affecting more than 2% of the population over the age of 65. Project Overview Parkinson’s Disease (PD) and Amyotrophic Lateral Sclerosis (ALS) are two of the most...

One of the greatest advancements in science over the past 10 years is the development of induced pluripotent stem cells (iPSCs). Project Overview One of the greatest advancements in science over the past 10 years is the development of induced pluripotent stem cells (iPSCs). These cells make it...